Enoch Healthcare | |
476 E Midvalley Rd Enoch UT 84721-7603 | |
(435) 263-0355 | |
(435) 263-0123 |
Full Name | Enoch Healthcare |
---|---|
Speciality | Family Medicine |
Location | 476 E Midvalley Rd, Enoch, Utah |
Authorized Official Name and Position | Ashley Starr (OFFICE MANAGER / COO) |
Authorized Official Contact | 4352630355 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Enoch Healthcare 376 East Midvalley Road Enoch UT 84721 Ph: (435) 263-0355 | Enoch Healthcare 476 E Midvalley Rd Enoch UT 84721-7603 Ph: (435) 263-0355 |
NPI Number | 1659945343 |
---|---|
Provider Enumeration Date | 05/17/2021 |
Last Update Date | 10/06/2022 |
Medicare PECOS PAC ID | 9739584053 |
---|---|
Medicare Enrollment ID | O20210825002410 |
News Archive
A high proportion of nursing facility residents were found to have low serum (blood) zinc concentrations during an observational study funded by the Agricultural Research Service (ARS) and the National Institute of Aging. The scientists found that those with normal blood zinc concentrations were about 50 percent less likely to develop pneumonia than those with low concentrations.
In an article published in the peer-reviewed, open-access SPIE publication Neurophotonics, "A multi-site microLED optrode array for neural interfacing," researchers present an implantable optrode array capable of exciting below-surface neurons in large mammal brains at two levels, both by structured-light delivery and large-volume illumination.
In a study to determine the non-medical factors that may be associated with the decision to treat nonmetastatic breast cancer, researchers at Columbia University Mailman School of Public Health evaluated the association between oncologist characteristics and the receipt of chemotherapy in elderly women with breast cancer and found that they were more likely to receive chemotherapy if treated by oncologists employed in a private practice.
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of the People's Republic of China (PRC) has issued a Notification of Granting Patent Rights for PRC 200480018784 which includes the use of nucleic acids, e.g., an siRNA, for the treatment of cancer. The patent describes modulation of claudins, which are proteins implicated in tumor progression and metastasis.
The same compound in a common household clothes detergent shows promise as a treatment to preserve muscle tissue after severe injury. Researchers at the Wake Forest Baptist Medical Center's Institute for Regenerative Medicine hope the oxygen-generating compound could one day aid in saving and repairing limbs and tissue.
› Verified 1 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1659945343 | NPI | - | NPPES |
1225432669 | Medicaid | UT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
363A00000X | Physician Assistant | (* (Not Available)) | Secondary |
News Archive
A high proportion of nursing facility residents were found to have low serum (blood) zinc concentrations during an observational study funded by the Agricultural Research Service (ARS) and the National Institute of Aging. The scientists found that those with normal blood zinc concentrations were about 50 percent less likely to develop pneumonia than those with low concentrations.
In an article published in the peer-reviewed, open-access SPIE publication Neurophotonics, "A multi-site microLED optrode array for neural interfacing," researchers present an implantable optrode array capable of exciting below-surface neurons in large mammal brains at two levels, both by structured-light delivery and large-volume illumination.
In a study to determine the non-medical factors that may be associated with the decision to treat nonmetastatic breast cancer, researchers at Columbia University Mailman School of Public Health evaluated the association between oncologist characteristics and the receipt of chemotherapy in elderly women with breast cancer and found that they were more likely to receive chemotherapy if treated by oncologists employed in a private practice.
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the State Intellectual Property Office of the People's Republic of China (PRC) has issued a Notification of Granting Patent Rights for PRC 200480018784 which includes the use of nucleic acids, e.g., an siRNA, for the treatment of cancer. The patent describes modulation of claudins, which are proteins implicated in tumor progression and metastasis.
The same compound in a common household clothes detergent shows promise as a treatment to preserve muscle tissue after severe injury. Researchers at the Wake Forest Baptist Medical Center's Institute for Regenerative Medicine hope the oxygen-generating compound could one day aid in saving and repairing limbs and tissue.
› Verified 1 days ago